# Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.

> **NCT00306696** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 388 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Rosiglitazone
- **DRUG:** spironolactone
- **DRUG:** hydrochlorothiazide
- **DRUG:** frusemide

## Key facts

- **NCT ID:** NCT00306696
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** —
- **Final completion:** 2004-01
- **Target enrollment:** 388 (ACTUAL)
- **Last updated:** 2016-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00306696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00306696, "Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00306696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*